Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1993 | 03-1993 | 12-1992 | 09-1992 | 06-1992 | |
| Sales | 1,958 | 2,138 | 2,364 | 2,447 | 3,207 |
| Cost of Goods | 8,981 | 8,948 | -6,440 | 6,440 | 0 |
| Gross Profit | -7,731 | -7,698 | 7,690 | -5,190 | 1,896 |
| Operating Expenses | 3,127 | 3,214 | 14,511 | 2,015 | 6,730 |
| Operating Income | -9,169 | -9,076 | -6,147 | -5,568 | -3,523 |
| Interest Expense | 260 | 243 | 227 | 195 | 176 |
| Other Income | 0 | 0 | 0 | 0 | 1 |
| Pre-tax Income | -9,429 | -9,318 | -6,374 | -5,763 | -3,699 |
| Net Income Continuous | -9,429 | -9,318 | -6,374 | -5,763 | -3,699 |
| Net Income Discontinuous | 0 | 0 | -1,998,000 | -1,998,000 | -1,998,000 |
| Net Income | $-9,429 | $-9,318 | $-6,374 | $-5,763 | $-3,699 |
| EPS Basic Total Ops | -0.61 | -0.61 | -0.42 | -0.38 | -0.24 |
| EPS Basic Continuous Ops | -0.61 | -0.61 | -0.42 | -0.38 | -0.24 |
| EPS Basic Discontinuous Ops | N/A | N/A | -130.14 | -130.17 | -130.16 |
| EPS Diluted Total Ops | -0.61 | -0.61 | -0.42 | -0.38 | -0.24 |
| EPS Diluted Continuous Ops | -1.11 | -0.61 | -0.42 | -0.38 | -0.24 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -130.15 | -130.17 | -130.17 |
| EBITDA(a) | $-9,169 | $-9,076 | $-6,147 | $-5,568 | $-3,523 |